BioMarin Pharmaceutical
BMRN
C$80.18
Share price
0.15%
Change (1 day)
-31.14%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Cash on Hand
Cash on Hand as of March 2025 : C$1.75 Billion
According to BioMarin Pharmaceutical's latest financial reports the company has C$1.75 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioMarin Pharmaceutical - Cash on Hand chart (from 1999 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | C$1.63 B | 14.63% |
| 2023-12-31 | C$1.42 B | -18.73% |
| 2022-12-31 | C$1.75 B | 35.63% |
| 2021-12-31 | C$1.29 B | -4.88% |
| 2020-12-31 | C$1.35 B | 37.98% |
| 2019-12-31 | C$0.98 B | -33.35% |
| 2018-12-31 | C$1.47 B | -15.84% |
| 2017-12-31 | C$1.75 B | 65.39% |
| 2016-12-31 | C$1.06 B | 29.09% |
| 2015-12-31 | C$0.82 B | -25.05% |
| 2014-12-31 | C$1.09 B | 31.31% |
| 2013-12-31 | C$0.83 B | 87.59% |
| 2012-12-31 | C$0.44 B | 124.39% |
| 2011-12-31 | C$0.19 B | -27.57% |
| 2010-12-31 | C$0.27 B | -13.39% |
| 2009-12-31 | C$0.31 B | -53.52% |
| 2008-12-31 | C$0.68 B | 16.51% |
| 2007-12-31 | C$0.58 B | 73.71% |
| 2006-12-31 | C$0.33 B | 504.41% |
| 2005-12-31 | C$55.64 M | -5.1% |
| 2004-12-31 | C$58.63 M | -78.1% |
| 2003-12-31 | C$0.26 B | 129.1% |
| 2002-12-31 | C$0.11 B | -44.05% |
| 2001-12-31 | C$0.20 B | 246.75% |
| 2000-12-31 | C$60.22 M | -33.7% |
| 1999-12-31 | C$90.84 M | 528.57% |
| 1998-12-31 | C$14.45 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | C$0.68 B | -61.14% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | C$34.66 M | -98.02% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | C$0.15 B | -90.99% | 🇺🇸 USA |
 Sanofi SNY | C$11.90 B | 579.49% | 🇫🇷 France |
 Amicus Therapeutics
FOLD | C$0.34 B | -80.31% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | C$0.79 B | -54.36% | 🇺🇸 USA |